BN vs. ELV
BN (Brookfield Corporation) and ELV (Elevance Health, Inc.) are both stocks. BN operates in Asset Management (Financial Services), while ELV operates in Healthcare Plans (Healthcare). Over the past 10 years, BN returned 14.29%/yr vs 11.88%/yr for ELV. At a 0.29 correlation, their price movements are largely independent.
Performance
BN vs. ELV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BN achieves a -7.32% return, which is significantly lower than ELV's 10.16% return. Over the past 10 years, BN has outperformed ELV with an annualized return of 14.29%, while ELV has yielded a comparatively lower 11.88% annualized return.
BN
- 1D
- -2.84%
- 1M
- -4.61%
- 6M
- -10.19%
- YTD
- -7.32%
- 1Y
- -4.91%
- 3Y*
- 22.29%
- 5Y*
- 9.95%
- 10Y*
- 14.29%
- ALL TIME*
- 9.05%
ELV
- 1D
- 2.44%
- 1M
- -1.61%
- 6M
- 3.01%
- YTD
- 10.16%
- 1Y
- 40.84%
- 3Y*
- -5.51%
- 5Y*
- 1.37%
- 10Y*
- 11.88%
- ALL TIME*
- 13.69%
BN vs. ELV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BN Brookfield Corporation | -7.32% | 20.54% | 44.18% | 28.60% | -34.80% | 49.30% | 8.99% | 52.68% | -10.65% | 33.82% |
ELV Elevance Health, Inc. | 10.16% | -3.14% | -20.72% | -6.89% | 11.83% | 46.12% | 7.74% | 16.33% | 18.11% | 58.72% |
Correlation
The correlation between BN and ELV is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Oct 30, 2001 | 0.29 |
The correlation between BN and ELV shifts across timeframes, from 0.09 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BN:
$94.68B
ELV:
$82.89B
BN:
$0.56
ELV:
$22.41
BN:
75.10
ELV:
17.06
BN:
1.31
ELV:
0.42
BN:
2.34
ELV:
1.86
BN:
$76.58B
ELV:
$201.11B
BN:
$27.02B
ELV:
$78.34B
BN:
$31.07B
ELV:
$8.01B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BN vs. ELV — Risk / Return Rank
BN
ELV
BN vs. ELV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Brookfield Corporation (BN) and Elevance Health, Inc. (ELV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BN | ELV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.31 | ||
| Sortino ratioReturn per unit of downside risk | -1.61 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.22 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.22 | 1.55 | -1.77 |
| Martin ratioReturn relative to average drawdown | -0.57 | 4.03 | -4.60 |
Loading charts...
Drawdowns
BN vs. ELV - Drawdown Comparison
The maximum BN drawdown since its inception was -82.22%, which is greater than ELV's maximum drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for BN and ELV.
Loading charts...
Drawdown Indicators
| BN | ELV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.22% | -67.19% | -15.03% |
Max Drawdown (1Y)Largest decline over 1 year | -22.05% | -26.49% | +4.44% |
Max Drawdown (3Y)Largest decline over 3 years | -27.84% | -50.38% | +22.54% |
Max Drawdown (5Y)Largest decline over 5 years | -41.85% | -50.38% | +8.53% |
Max Drawdown (10Y)Largest decline over 10 years | -51.42% | -50.38% | -1.04% |
Current DrawdownCurrent decline from peak | -13.50% | -29.50% | +16.00% |
Average DrawdownAverage peak-to-trough decline | -28.47% | -15.34% | -13.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.66% | 10.17% | -1.51% |
Volatility
BN vs. ELV - Volatility Comparison
The current volatility for Brookfield Corporation (BN) is 6.07%, while Elevance Health, Inc. (ELV) has a volatility of 14.46%. This indicates that BN experiences smaller price fluctuations and is considered to be less risky than ELV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BN | ELV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.07% | 14.46% | -8.39% |
Volatility (6M)Calculated over the trailing 6-month period | 22.15% | 29.88% | -7.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.18% | 36.33% | -8.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.24% | 29.61% | +1.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.16% | 31.11% | -0.95% |
Dividends
BN vs. ELV - Dividend Comparison
BN's dividend yield for the trailing twelve months is around 0.61%, less than ELV's 1.79% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BN Brookfield Corporation | 0.61% | 0.52% | 0.56% | 0.70% | 1.44% | 1.12% | 1.55% | 1.11% | 1.56% | 1.29% | 1.58% | 1.50% |
ELV Elevance Health, Inc. | 1.79% | 1.95% | 1.77% | 1.26% | 1.00% | 0.98% | 1.18% | 1.06% | 1.14% | 1.20% | 1.81% | 1.79% |
Financials
BN vs. ELV - Financials Comparison
This section allows you to compare key financial metrics between Brookfield Corporation and Elevance Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BN vs. ELV - Profitability Comparison
BN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Brookfield Corporation reported a gross profit of 4.43B and revenue of 18.39B. Therefore, the gross margin over that period was 24.1%.
ELV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Elevance Health, Inc. reported a gross profit of 44.98B and revenue of 50.47B. Therefore, the gross margin over that period was 89.1%.
BN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Brookfield Corporation reported an operating income of 4.39B and revenue of 18.39B, resulting in an operating margin of 23.9%.
ELV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Elevance Health, Inc. reported an operating income of 2.06B and revenue of 50.47B, resulting in an operating margin of 4.1%.
BN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Brookfield Corporation reported a net income of 100.59M and revenue of 18.39B, resulting in a net margin of 0.6%.
ELV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Elevance Health, Inc. reported a net income of 1.46B and revenue of 50.47B, resulting in a net margin of 2.9%.
Frequently Asked Questions
BN and ELV have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ELV has higher volatility (14.46%) compared to BN (6.07%). In terms of maximum drawdown, BN dropped -82.22% vs ELV's -67.19%.
ELV currently has the higher Sharpe Ratio (1.13 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BN and ELV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer